US Judge Sets Jury Selection in Luigi Mangione CEO Killing Trial for September
Jury selection is scheduled for early September as the accused challenges death penalty pursuit and indictment in the federal case over a 2024 CEO shooting.
8 Articles
8 Articles
Jury selection set for September in Luigi Mangione’s trial | Honolulu Star-Advertiser
NEW YORK >> A federal judge today said jury selection will begin in early September for the murder trial of Luigi Mangione, the man accused of gunning down a health insurance executive outside a hotel in Manhattan.
New York, Jan. 9 (EFE).- Luigi Mangione, accused of murdering the UnitedHealthcare Executive Director, Brian Thompson, in December 2024, returns this Friday to court with a hearing in Manhattan, where key motions for his defense are expected to be debated before his federal trial, scheduled for 2026. Mangione, 27, was arrested five days after the murder at a McDonald’s in Altoona, Pennsylvania.
US judge sets jury selection in Luigi Mangione CEO killing trial for September
A federal judge on Friday said jury selection will begin in early September for the murder trial of Luigi Mangione, the man accused of gunning down a health insurance executive outside a hotel in Manhattan.
On Friday (January 9), Luigi Mangione, the suspect in the murder of UnitedHealth CEO Brian Thompson a year ago, returned to federal court for a crucial hearing. His lawyers are attempting to block the federal government's attempt to seek the death penalty for him. The judge stated that a ruling will be issued later in the form of a written order; jury selection may begin in September.
Jury selection set for September in Mangione Trial
A federal judge announced that jury selection in the murder trial of Luigi Mangione is set for early September. Mangione, 27, is accused of fatally shooting Brian Thompson, CEO of UnitedHealth Group’s health insurance unit, outside a Manhattan hotel in December 2024. The big picture: U.S. District Judge Margaret Garnett scheduled the jury selection at a hearing packed with spectators. The trial’s evidence phase will be scheduled depending on wh…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium






